Resivant Medical has announced that it has received FDA 510(k) clearance for its Cutiva™ Topical Skin Adhesive and Cutiva PLUS™ Skin Closure System.

This achievement represents a significant advancement in medical adhesive and wound closure technology, marking the first major development in this area in over 25 years.

The Cutiva platform introduces a breakthrough in cyanoacrylate adhesive technology for surgical incisions and traumatic lacerations.

The unique formulation of the Cutiva adhesive maintains a clean incision site without the need for additional dressings and is designed to reduce skin irritants.

The Cutiva adhesive combines the strong bonding capabilities of super glue with the advantages of crosslinked silicone rubber.

This creates a skin adhesive that offers robust wound closure, enhanced flexibility, durability, and improved patient safety and comfort.

The products are delivered via a single-handed applicator that features a high-viscosity, no-run liquid adhesive, ensuring precise application and preventing unwanted spreading.

The Cutiva PLUS system, which includes a surgical mesh and the innovative adhesive, allows for easy removal without damaging the surrounding skin and is suitable for a broad range of surgical applications.




Source: resivantmedical.com

Report Abuse